Search clinical trials for: Modulation of FiO2

Total 10000 results

‹
1
2
...
105
106
107
108
109
110
111
...
199
200
›

Università degli Studi dell'Insubria

Terminated

Fondaparinux 1,5 mg for the Prevention of Venous Thromboembolism (VTE) in Medical Patients With Renal Insufficiency

Renal Insufficiency | Medical Patients

Italy
TTY Biopharm

Terminated

Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve

Carcinoma, Hepatocellular

Taiwan
Novartis

Terminated

Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

Macular Degeneration | Choroidal Neovascularization

United Kingdom, Spain, Netherlands, Hungary, Italy, Denmark, Belgium, Austria, France, Germany, Poland, Switzerland
Medical University of Vienna

Completed

Thalidomide in Mucosa Associated Lymphoid Tissue (MALT) Lymphoma Patients

MALT Lymphoma

Austria
SCRI Development Innovations, LLC
CTI BioPharma

Completed

Arsenic Trioxide and Thalidomide in the Treatment of Refractory Multiple Myeloma

Multiple Myeloma
ARCA Biopharma, Inc.

Suspended

Safety Study of Recombinant NAPc2 to Prevent Tumor Progression and Metastases in Metastatic Colon Cancer

Colon Cancer

United States
Marquette University

Completed

Comparison of Two Internet Supported Natural Family Planning Methods

Pregnancy

United States
Albert Schweitzer Hospital
Medical University of Vienna

Completed

Relapses in Plasmodium Ovale and Efficacy of Artemether-lumefantrine for Mixed Species and Non-falciparum Malaria (REPLAMO)

Malaria

Gabon
Sohag University

Not yet recruiting

Polidocanol 1% and Steroid in Keloids and Hypertrophic Scars

Keloid and Hypertrophic Scars

Egypt
Ahi Evran University Education and Research Hospital

Recruiting

Comparison of the Effect of Genicular Nerve Block and Physical Therapy in Patients With Knee Osteoarthritis

Knee Osteoarthritis

Turkey (Türkiye)
Center for Human Reproduction

Withdrawn

Does Letrozole Improve the Outcomes and/or Reduce the Cost of IVF-ET Cycles? (Cost-Less)

Infertility

United States
University of Illinois at Urbana-Champaign

Not yet recruiting

5 Verbs for Couples - Pilot Study

Relationships, Marital
Region Skane
Lund University

Recruiting

Evaluation of a Family-centered Program for Problematic Gaming/Excessive Screen Use (S-FAME)

Adolescent Behavior | Family Relations | Social Media Addiction | Gaming Disorder

Sweden
Hospices Civils de Lyon

Not yet recruiting

Community Screening and Management of Hepatitis B, C and Delta in the Mongolian Population Living in France (Mondelta)

Hepatitis D | Hepatocellular Carcinoma (HCC) | Liver Fibrosis | HEPATITIS C (HCV) | Hepatitis B Virus (HBV)

France
Brigham and Women's Hospital
Centers for Disease Control and Prevention

Completed

A School-Based Intervention to Reduce Lyme Disease

Lyme Disease
Sun Yat-sen University

Not yet recruiting

Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer

Gastric (Cardia, Body) Cancer
Affiliated Hospital of Nantong University

Recruiting

Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC

Colorectal Neoplasms Malignant

China
Tesaro, Inc.

Completed

A Study of Niraparib Combined With Bevacizumab Maintenance Treatment in Participants With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Ovarian Neoplasms

United States
Exelixis

Active, not recruiting

Study of XL092 + Nivolumab vs Sunitinib in Subjects With Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma (STELLAR-304)

Non-Clear Cell Renal Cell Carcinoma

United States, Argentina, Australia, Brazil, Bulgaria, Chile, Croatia, Czechia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Malaysia, Netherlands, Poland, Singapore, Slovakia, Spain, Thailand, Turkey, United Kingdom
BeiGene

Completed

Zanubrutinib, in Combination With Lenalidomide, With or Without Rituximab in Participants With Relapsed/Refractory Diffuse Large B-Cell Lymphoma

Relapsed/Refractory Diffuse Large B-Cell Lymphoma

China
David O'Malley
Genentech, Inc.

Completed

Study of Intraperitoneal Carboplatin with IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cancer | No Prior Chemotherapy

United States
Koen van Besien

Completed

Vactosertib in Combination w/ Pomalidomide in Relapsed or Relapsed and Refractory Multiple Myeloma

Multiple Myeloma

United States
University of Maryland, Baltimore
Amgen

Terminated

Erenumab-aooe for Temporomandibular Disorders Management: TMD Cgrp Antibody RElief (TMD CARE) (TMD CARE)

Temporomandibular Disorders

United States
Clearside Biomedical, Inc.

Completed

Safety and Tolerability Study of Suprachoroidal Injection of CLS-AX Following Anti-VEGF Therapy in Neovascular AMD (OASIS)

Neovascular Age-related Macular Degeneration

United States
Celgene

Completed

A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM) (KarMMa-4)

Multiple Myeloma

United States
Nasser Hanna
Genentech, Inc.

Terminated

Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer

NSCLC Stage IV | NSCLC, Recurrent

United States
Brian Hill
The Cleveland Clinic

Terminated

Lenalidomide, Ixazomib, and Rituximab as Front-Line Therapy for High Risk Indolent B-Cell Lymphoma

Lymphoma | B Cell Lymphoma

United States
The First Affiliated Hospital with Nanjing Medical...
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Active, not recruiting

Pemetrexed and TAS-102 in Combination With Bevacizumab in Refractory Colorectal Cancer

Colorectal Neoplasms

China
The First Affiliated Hospital with Nanjing Medical...
Jiangsu HanSoh Tharmaceutical Group Co., Ltd

Withdrawn

Pemetrexed and S-1 in Combination With Bevacizumab in Refractory Colorectal Cancer

Colorectal Neoplasms

China
Aljazeera Hospital
Cairo University

Unknown

Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy.

Myoma

Egypt
Zhejiang Teruisi Pharmaceutical Inc.

Unknown

A Study to Compare the Similarity in Efficacy and Safety Between TRS003 and China-approved Bevacizumab® in NSCLC (NSCLC)

Advanced Non-squamous Non-small-cell Lung Cancer

China
University of Cincinnati
Eisai Inc.

Withdrawn

Surgery With Implantable Biodegradable Carmustine (BCNU) Wafer Followed by Chemo for Patients With Recurrent Glioblastoma Multiforme

Glioblastoma Multiforme

United States
Kobe City General Hospital

Terminated

The Safety and Efficacy of Pemetrexed Rechallenge With Bevacizumab

Advanced Non-small Cell Lung Cancer

Japan
Boehringer Ingelheim

Completed

Patient Convenience Study- NIS RELATE

Atrial Fibrillation

Korea, Republic of, Malaysia, Singapore, Thailand, Indonesia
Hoffmann-La Roche

Completed

A Study of Bevacizumab Added to Trastuzumab Plus Docetaxel in the Neoadjuvant Setting in Participants With Early Stage HER2-Positive Breast Cancer (AVATAXHER)

Breast Cancer

France
Lund University Hospital
Mundipharma Pte Ltd.; Roche Pharma AG; Celgene

Completed

Lenalidomide, Bendamustine and Rituximab as First-line Therapy for Patients Over 65 Years With Mantle Cell Lymphoma. (LENA-BERIT)

Mantle Cell Lymphoma

Finland, Denmark, Norway, Sweden
Qingdao Central Hospital

Completed

Osimertinib or Docetaxel-bevacizumab as Third-line Treatment in EGFR T790M Mutated Non-Small Cell Lung Cancer

Progression Free Survival

China
Spanish Cooperative Group for the Treatment of...
Hoffmann-La Roche

Completed

Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients (AVAXIRI)

Metastatic Colorectal Cancer

Spain
Genentech, Inc.

Completed

A Study of Bevacizumab With Carboplatin and Paclitaxel Chemotherapy for the First-Line Treatment of Patients With Metastatic Melanoma (BEAM)

Melanoma
Qilu Pharmaceutical Co., Ltd.
Tianjin Medical University Cancer Institute and Hospital

Unknown

To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer

Non Small Cell Lung Cancer

China
The Cleveland Clinic
Genentech, Inc.

Completed

Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer

Endometrial Carcinoma

United States
Hoosier Cancer Research Network
University of Colorado, Denver; McGill University; United States Department of... and other collaborators

Terminated

Predicting Response and Toxicity in Patients Receiving Paclitaxel and Avastin for Breast Cancer

Breast Cancer

United States
Hoffmann-La Roche

Completed

A Feasibility Trial of Avastin (Bevacizumab) in Combination With Concomitant Chemoradiation (Cisplatin and Vinorelbine) in Patients With Locally Advanced Non-Squamous Non-Small Cell Lung Cancer.

Non-Squamous Non-Small Cell Lung Cancer

Canada
Genentech, Inc.

Completed

Study Evaluating the Safety and Efficacy of MEGF0444A in Combination With Carboplatin, Paclitaxel and Bevacizumab in Patients With Advanced or Recurrent Non-Squamous Non-Small Cell Lung Cancer Who Have Not Received Prior Chemotherapy for Advanced Disease (NILE)

Non-Squamous Non-Small Cell Lung Cancer

Australia, United States, Hungary, France, Germany, Czech Republic, Poland
Hellenic Oncology Research Group

Completed

Paclitaxel, Carboplatin Plus Bevacizumab in Pretreated, Advanced or Metastatic Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Greece
University of Utah
Genentech, Inc.

Completed

Bevacizumab (Avastin®) + Erlotinib as First-line Therapy for Stage IIIB/IV or Recurrent, Non-squamous Cell Lung Cancer

Cancer

United States
Sidney Kimmel Comprehensive Cancer Center at Johns...

Terminated

Phase II Study of Doxorubicin and Avastin® in Sarcoma.

Sarcoma | Soft Tissue Sarcoma

United States
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Bevacizumab, Cisplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Lung Cancer
Hoffmann-La Roche

Completed

A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Primary Breast Cancer

Breast Cancer

Austria
Eli Lilly and Company

Completed

A Study of Pemetrexed and Bevacizumab for Participants With Advanced Non-Small Cell Cancer

Non-Small Cell Lung Cancer

Italy, Germany, Spain, Sweden, Denmark

‹
1
2
...
105
106
107
108
109
110
111
...
199
200
›

Subscribe